We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Russian Prime Minister Mikhail Fradkov has signed a resolution approving a new insurance program for doctors, pharmaceutical sector workers and other people with hazardous occupations, the government's press service said on Friday.
PhotoCure together with GE Healthcare, their licensing partner for Hexvix, initiated the introduction of Hexvix in Europe at the 21st EAU annual meeting in Paris April 5-7.
Israeli drugmaker Can-Fite BioPharma has signed a memorandum of understanding with an unnamed Japanese company that outlicenses the rights for use of CF101, Can-Fite's anti-inflammatory medication, in Japan.
Since the introduction of Wyeth's Prevnar (pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)), in the U.S. in 2000, the rate of antibiotic-resistant invasive pneumococcal disease (IPD) has substantially decreased in infants and young children, according to a study published in the New England Journal of Medicine.
Radiotherapy combined with nedaplatin -- a second-generation platinum complex -- and 5-fluorouracil (5-FU) can help combat postoperative recurrent esophageal cancer, according to research conducted by physicians at Japan's Tohoku University School of Medicine and published in the British medical journal BMC Cancer.
Japanese durgmakers Astellas and Toyama Chemical have entered into a licensing agreement for the development and marketing of the antibiotic T-3811 (garenoxacin).
Researchers at the University of Illinois at Chicago and two other institutions have unraveled the structure of an important new drug target from the virus that causes SARS, severe acute respiratory syndrome.
Dong-A Pharmaceutical Co., one of Korea's leading pharmaceutical manufacturers, is strengthening its research and development in order to meet demands in emerging markets from bio-technology to health food and the environmental business field.